Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Xanthine dehydrogenase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium ulcerans | carbon monoxyde dehydrogenase large chain CoxL | Get druggable targets OG5_127252 | All targets in OG5_127252 |
Mycobacterium ulcerans | aerobic-type carbon monoxide dehydrogenase subunit CoxL_2 | Get druggable targets OG5_127252 | All targets in OG5_127252 |
Mycobacterium tuberculosis | Probable carbon monoxyde dehydrogenase (large chain) | Get druggable targets OG5_127252 | All targets in OG5_127252 |
Trichomonas vaginalis | xanthine dehydrogenase, putative | Get druggable targets OG5_127252 | All targets in OG5_127252 |
Trichomonas vaginalis | xanthine dehydrogenase, putative | Get druggable targets OG5_127252 | All targets in OG5_127252 |
Trichomonas vaginalis | aldehyde oxidase, putative | Get druggable targets OG5_127252 | All targets in OG5_127252 |
Mycobacterium ulcerans | carbon monoxide dehydrogenase | Get druggable targets OG5_127252 | All targets in OG5_127252 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.1091 | 1 | 1 |
Mycobacterium ulcerans | carbon monoxide dehydrogenase | 0.0139 | 0.0744 | 1 |
Trichomonas vaginalis | xanthine dehydrogenase, putative | 0.0209 | 0.1431 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.1091 | 1 | 1 |
Schistosoma mansoni | inhibitor of apoptosis protein | 0.1091 | 1 | 1 |
Mycobacterium ulcerans | aerobic-type carbon monoxide dehydrogenase subunit CoxL_2 | 0.0099 | 0.0356 | 0.4783 |
Echinococcus granulosus | baculoviral IAP repeat containing protein | 0.1091 | 1 | 1 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.1091 | 1 | 1 |
Echinococcus multilocularis | inhibitor of apoptosis protein | 0.1091 | 1 | 1 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase medium chain CoxM | 0.0071 | 0.0084 | 0.1125 |
Trichomonas vaginalis | xanthine dehydrogenase, putative | 0.0209 | 0.1431 | 0.5 |
Echinococcus multilocularis | baculoviral IAP repeat containing protein | 0.1091 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1091 | 1 | 1 |
Mycobacterium ulcerans | aerobic-type carbon monoxide dehydrogenase subunit CoxM_2 | 0.0071 | 0.0084 | 0.1125 |
Schistosoma mansoni | inhibitor of apoptosis (iap) domain family member | 0.1091 | 1 | 1 |
Mycobacterium tuberculosis | Probable carbon monoxyde dehydrogenase (large chain) | 0.0099 | 0.0356 | 1 |
Echinococcus granulosus | inhibitor of apoptosis protein | 0.1091 | 1 | 1 |
Onchocerca volvulus | Deterin homolog | 0.1091 | 1 | 1 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase large chain CoxL | 0.0099 | 0.0356 | 0.4783 |
Onchocerca volvulus | 0.1091 | 1 | 1 | |
Trichomonas vaginalis | aldehyde oxidase, putative | 0.0209 | 0.1431 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 3.1 nM | BindingDB_Patents: Inhibition Assay. Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 well plates at 50 µL/well. In addition, test compounds diluted with PBS were added at 50 µL/well. Xanthine (Wako) at 200 µM prepared with PBS was added at 100 µL/well, and the reaction was conducted for 10 minutes at room temperature. Absorbance at 290 nm was measured using a microplate reader SpectraMax Plus 384 (Molecular device). The absorbance under a condition without xanthine is 0%, and control without test compounds is 100%. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.